Isolation and study of an acquired inhibitor of human coagulation factor V. (Q34520485)

2 August 2017

title

Isolation and study of an acquired inhibitor of human coagulation factor V. (English)

1 reference

2 August 2017

M E Nesheim

1 reference

2 August 2017

W L Nichols

1 reference

2 August 2017

T L Cole

1 reference

2 August 2017

J G Houston

1 reference

2 August 2017

R B Schenk

1 reference

2 August 2017

K G Mann

1 reference

2 August 2017

E J Bowie

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 1986

1 reference

Journal of Clinical Investigation

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

405-415

1 reference

Assembly of the prothrombinase complex in the absence of prothrombin.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Isolation of functional human coagulation factor V by using a hybridoma antibody

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Immunochemical characterization of factor VIII inhibitors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Quantitative features of the structure, function and modulation of prothrombinase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Molecular Weight Determination of Protein-Dodecyl Sulfate Complexes by Gel Electrophoresis in a Discontinuous Buffer System

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Nature of the defect in congenital factor V deficiency: study in a patient with an acquired circulating anticoagulant

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

A Specific Inhibitor of Human Clotting Factor V

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

A circulating anticoagulant against factor V

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Factor V Inhibitor: Report of a Case, with Comments on a Possible Effect of Streptomycin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Acquired inhibitors of blood coagulation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Preparation of suspensions of washed platelets from humans.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Factor V anticoagulants: clinical, biochemical, and immunological observations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

A case of factor V inhibitor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

A simple method for the preparation of homogeneous phospholipid vesicles

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

A circulating anticoagulant against factor V.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

The contribution of bovine Factor V and Factor Va to the activity of prothrombinase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Basic Mechanisms in Blood Coagulation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

A monoclonal IgG4 (lambda) with factor V inhibitory activity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Observations on a Factor-V Inhibitor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

Factor V inhibitor and bullous pemphigoid

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

"Clotspeed," a mathematical simulation of the functional properties of prothrombinase.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423360

27 October 2018

1 reference

12 December 2020

Hemorrhagic death associated with a high titer factor V inhibitor

1 reference

12 December 2020

Factor V antibody and disseminated intravascular coagulation

1 reference

12 December 2020

Properties of the factor Xa binding site on human platelets

1 reference

12 December 2020

Acquired inhibitors of factor V

1 reference

12 December 2020

[Factor V inhibitor developing in a patient with pulmonary tuberculosis (author's transl)]

1 reference

12 December 2020

Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions

1 reference

12 December 2020

Coordinate binding of factor Va and factor Xa to the unstimulated platelet

1 reference

12 December 2020

[A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)]

1 reference

12 December 2020

Cofactor dependence of factor Xa incorporation into the prothrombinase complex

1 reference

12 December 2020

[A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study (author's transl)]

1 reference

12 December 2020

A Simplified Procedure for Purification of Human Prothrombin, Factor IX and Factor X

1 reference

12 December 2020

An inhibitor against factor V occurring postoperatively in a case of pancreatic cancer

1 reference

12 December 2020

1 reference

12 December 2020

Radioimmunoassay of factor V in human plasma and platelets

1 reference

12 December 2020

Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure

1 reference

12 December 2020

Hemorrhagic syndrome caused by a circulating antifactor V anticoagulant. Correction by transfusion of fresh frozen plasma and plasma exchange

1 reference

12 December 2020

A circulating anticoagulant specific for factor V

1 reference

12 December 2020

The response of an acquired Factor V inhibitor to activated Factor IX concentrate

1 reference

12 December 2020

Immune complexes containing factor V in a patient with an acquired neutralizing antibody

1 reference

12 December 2020

A circulation inhibitor (anti-AcG) specific for the labile factor-V of the blood-clotting mechanism

1 reference

12 December 2020

Massive hemorrhage associated with circulating antibodies to factor V

1 reference

12 December 2020

A Circulating Factor V Inhibitor: Possible Side Effect of Treatment with Streptomycin

1 reference

12 December 2020

Proceedings: A high titre circulating inhibitor of human factor V: clinical, biochemical and immunological features and its treatment by plasmapheresis

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI112318

1 reference

release_ddbnjqfryncs3h7e4cook36sku

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ddbnjqfryncs3h7e4cook36sku

24 November 2022

mapped directly with Wikidata item

PMC publication ID

423360

1 reference

2 August 2017

1 reference